Lobbyist Public Search |
|
Records prior to registration year 2005 are not available online.
Contact the Lobbyist Division here for assistance.
|
Search data is collected from registration records and disclosure reports
submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining
lobbying services to register annually, and submit disclosure reports twice a year.
|
Your comments are welcome:
submit feedback
|
|
Account summary |
|
Search detail for: |
Indivior Inc.
|
Registration year: |
2019 |
Registration type:
|
Client
|
Address:
|
10710 Midlothian Turnpike Suite 430 Midlothian, VA, 23235 USA / 804-402-1297
|
Lobbyist information
|
Amount
|
Gary Riddle
|
$0.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
01/01/2019
|
|
Any and all matters pertaining to Indivior including medication-assisted treatment, SB 1214 An Act to enhance access to prescription information and overdose reporting for care coordination, HB 2633 An Act relative to the taxation of the sale of active opioids.
|
|
Nicholas John Casale
|
$0.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
08/05/2019
|
|
Medication Assisted Treatment, Opioid Use Disorder, Sublocade, Mental Health
|
|
Nicholas Primpas
|
$0.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
01/01/2019
|
|
Any and all matters pertaining to Indivior including medication-assisted treatment, SB 1214 An Act to enhance access to prescription information and overdose reporting for care coordination, HB 2633 An Act relative to the taxation of the sale of active opioids.
|
|
William Mullen
|
$0.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
01/01/2019
|
|
Any and all matters pertaining to Indivior including medication-assisted treatment, SB 1214 An Act to enhance access to prescription information and overdose reporting for care coordination, HB 2633 An Act relative to the taxation of the sale of active opioids.
|
|
Total salaries paid:
$0.00
|
|
|
Total salaries paid:
$54,000.00
|
|
* No expense has been disclosed.
|
|
Disclosure Report details
|
|
|
|